116 related articles for article (PubMed ID: 18410999)
1. Hdm2 and nitric oxide radicals contribute to the p53-dependent radioadaptive response.
Takahashi A; Matsumoto H; Ohnishi T
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):550-8. PubMed ID: 18410999
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide radicals choreograph a radioadaptive response.
Matsumoto H; Takahashi A; Ohnishi T
Cancer Res; 2007 Sep; 67(18):8574-9. PubMed ID: 17875696
[TBL] [Abstract][Full Text] [Related]
3. Biphasic effects of nitric oxide radicals on radiation-induced lethality and chromosome aberrations in human lung cancer cells carrying different p53 gene status.
Su X; Takahashi A; Guo G; Mori E; Okamoto N; Ohnishi K; Iwasaki T; Ohnishi T
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):559-65. PubMed ID: 20381264
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide is an initiator of intercellular signal transduction for stress response after hyperthermia in mutant p53 cells of human glioblastoma.
Matsumoto H; Hayashi S; Hatashita M; Ohnishi K; Ohtsubo T; Kitai R; Shioura H; Ohnishi T; Kano E
Cancer Res; 1999 Jul; 59(13):3239-44. PubMed ID: 10397271
[TBL] [Abstract][Full Text] [Related]
5. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide radical-induced radioadaptation and radiosensitization are G2/M phase-dependent.
Su X; Takahashi A; Kondo N; Nakagawa Y; Iwasaki T; Guo G; Ohnishi T
J Radiat Res; 2011; 52(5):609-15. PubMed ID: 21757848
[TBL] [Abstract][Full Text] [Related]
7. Contribution of radiation-induced, nitric oxide-mediated bystander effect to radiation-induced adaptive response.
Matsumoto H; Ohnishi T
Biol Sci Space; 2004 Nov; 18(3):108-9. PubMed ID: 15858344
[TBL] [Abstract][Full Text] [Related]
8. HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas.
Sosin AM; Burger AM; Siddiqi A; Abrams J; Mohammad RM; Al-Katib AM
J Hematol Oncol; 2012 Sep; 5():57. PubMed ID: 22989009
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells.
Elison JR; Cobrinik D; Claros N; Abramson DH; Lee TC
Arch Ophthalmol; 2006 Sep; 124(9):1269-75. PubMed ID: 16966622
[TBL] [Abstract][Full Text] [Related]
11. Indirect influences of radiation on unirradiated cells through irradiated cells.
Matsumoto H; Ohnishi T
Biol Sci Space; 2003 Oct; 17(3):257-8. PubMed ID: 14676405
[TBL] [Abstract][Full Text] [Related]
12. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway.
Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P
J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964
[TBL] [Abstract][Full Text] [Related]
13. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
LaRusch GA; Jackson MW; Dunbar JD; Warren RS; Donner DB; Mayo LD
Cancer Res; 2007 Jan; 67(2):450-4. PubMed ID: 17234751
[TBL] [Abstract][Full Text] [Related]
14. Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.
Patton JT; Mayo LD; Singhi AD; Gudkov AV; Stark GR; Jackson MW
Cancer Res; 2006 Mar; 66(6):3169-76. PubMed ID: 16540668
[TBL] [Abstract][Full Text] [Related]
15. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
[TBL] [Abstract][Full Text] [Related]
16. Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line.
Grünbaum U; Meye A; Bache M; Bartel F; Würl P; Schmidt H; Dunst J; Taubert H
Anticancer Res; 2001; 21(3B):2065-71. PubMed ID: 11497299
[TBL] [Abstract][Full Text] [Related]
17. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.
Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V
Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278
[TBL] [Abstract][Full Text] [Related]
18. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.
Cheok CF; Dey A; Lane DP
Mol Cancer Res; 2007 Nov; 5(11):1133-45. PubMed ID: 18025259
[TBL] [Abstract][Full Text] [Related]
20. Induction of radioresistance by a nitric oxide-mediated bystander effect.
Matsumoto H; Hayashi S; Hatashita M; Ohnishi K; Shioura H; Ohtsubo T; Kitai R; Ohnishi T; Kano E
Radiat Res; 2001 Mar; 155(3):387-96. PubMed ID: 11182788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
